Dr.'s Frias, Sacha, Bianchi: Since 2014, the NI
Post# of 148675
(Total Views: 416)
Posted On: 10/13/2024 8:26:29 AM
Dr.'s Frias, Sacha, Bianchi:
Since 2014, the NICHD has funded the Human Placenta Project (HPP) aimed at generating an improved understanding of human placental biology and developing innovative tools and approaches for real-time assessment of the placenta across gestation.
___
"Diana Bianchi, MD: Thanks for introducing the Human Placenta Project, which has been a significant investment for the NICHD. We've invested around $80 million into this program. Now that we're just about 6 years into the program, it's a great time to take stock. As you mentioned, we're very interested in the placenta. In fact, we often say that the placenta is NICHD's organ. None of the other institutes at the National Institutes of Health (NIH) seem to dispute that claim. It's the one organ for which we can say that we really are the lead research funders."
___
"After much discussion, however, 1 of our 5 scientific themes is related to pregnancy, not just pregnancy per se or pregnancy ending after 8 or 9 months. Rather, it's really how pregnancy sets the foundation for a lifetime of well-being. So that brings us to the human side of the project or the HPP. The HPP was designed to noninvasively and in real time determine what is a typically developing placenta doing and what is an atypically developing placenta doing, and how can you best monitor that, because although you can examine a placenta, it's only accessible after the baby has been born. So, how can you prospectively identify or distinguish between pregnancies that are going well and those that are not going well and perhaps target management accordingly? "
___
" In particular, there are several HPP-funded investigators, such as Drs. Ellen Grant at Harvard,1 Sherin Devaskar at UCLA,2,3 and Antonio Frias at Oregon Health Sciences University,4 who are leading these efforts."
https://www.clinicaltherapeutics.com/article/...1/fulltext
___
Dr. Sacha & Dr. Frias worked on the DOD Zika grant.
Dr. Bianchi through NICD:
"NICHD's research focuses on the biology, prevention, and treatment of HIV/AIDS in infants, children, adolescents, and women, including pregnant and breastfeeding women."
___
It's always asked when NIH is going to fund an LC trial, etc..
NICD is the federal agency to really be involved with on multiple, significant treatments.
Now that we have FcRn & resevoir surprise news, federal NICD is not to be overlooked.
The very best source, for complimenting LL-PLS / bNab & their goal of eliminating & or, reducing, ART
Since 2014, the NICHD has funded the Human Placenta Project (HPP) aimed at generating an improved understanding of human placental biology and developing innovative tools and approaches for real-time assessment of the placenta across gestation.
___
"Diana Bianchi, MD: Thanks for introducing the Human Placenta Project, which has been a significant investment for the NICHD. We've invested around $80 million into this program. Now that we're just about 6 years into the program, it's a great time to take stock. As you mentioned, we're very interested in the placenta. In fact, we often say that the placenta is NICHD's organ. None of the other institutes at the National Institutes of Health (NIH) seem to dispute that claim. It's the one organ for which we can say that we really are the lead research funders."
___
"After much discussion, however, 1 of our 5 scientific themes is related to pregnancy, not just pregnancy per se or pregnancy ending after 8 or 9 months. Rather, it's really how pregnancy sets the foundation for a lifetime of well-being. So that brings us to the human side of the project or the HPP. The HPP was designed to noninvasively and in real time determine what is a typically developing placenta doing and what is an atypically developing placenta doing, and how can you best monitor that, because although you can examine a placenta, it's only accessible after the baby has been born. So, how can you prospectively identify or distinguish between pregnancies that are going well and those that are not going well and perhaps target management accordingly? "
___
" In particular, there are several HPP-funded investigators, such as Drs. Ellen Grant at Harvard,1 Sherin Devaskar at UCLA,2,3 and Antonio Frias at Oregon Health Sciences University,4 who are leading these efforts."
https://www.clinicaltherapeutics.com/article/...1/fulltext
___
Dr. Sacha & Dr. Frias worked on the DOD Zika grant.
Dr. Bianchi through NICD:
"NICHD's research focuses on the biology, prevention, and treatment of HIV/AIDS in infants, children, adolescents, and women, including pregnant and breastfeeding women."
___
It's always asked when NIH is going to fund an LC trial, etc..
NICD is the federal agency to really be involved with on multiple, significant treatments.
Now that we have FcRn & resevoir surprise news, federal NICD is not to be overlooked.
The very best source, for complimenting LL-PLS / bNab & their goal of eliminating & or, reducing, ART
(6)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼